HD

Hetal Darshan Khimani

Active Director Designated Partner DIN 11801210
DIN 11801210 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Hetal Darshan Khimani

Hetal Darshan Khimani is a Designated Partner at Cerata Biotech Llp (since 2026).

DIN 11801210
Primary Designation Designated Partner
First Appointment 02 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Jul 20262026Active

Board colleagues of Hetal Darshan Khimani

NameDINCompanyDesignation
Darshan Mohanbhai Khimani10015095Cerata Biotech LlpDesignated Partner
Pratik Dhirubhai Kansara10015096Cerata Biotech LlpDesignated Partner
Vishva Pratik Kansara11801209Cerata Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cerata Biotech Llp
Premium access

Shareholding and investment profile for Hetal Darshan Khimani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hetal Darshan Khimani

Hetal Darshan Khimani currently holds 1 directorship: Cerata Biotech Llp (Designated Partner, since 02 Jul 2026).

Hetal Darshan Khimani was first appointed on 02 Jul 2026 as Designated Partner at Cerata Biotech Llp.

The current boards of Hetal Darshan Khimani's companies include Darshan Mohanbhai Khimani (Cerata Biotech Llp), Pratik Dhirubhai Kansara (Cerata Biotech Llp), Vishva Pratik Kansara (Cerata Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available